Claire Clelland is a Neurology physician affiliated with University of California, San Francisco. OpenAlex indexes 44 publications with 2,660 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Ucsf Neurology Department
505 Parnassus Avenue, Box 0114
San Francisco, CA 941430114
Telephone
415-476-1489Registry record last updated 19 Mar 2016.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- LEICA MICROSYSTEMS INC.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%SSRI70.4%Escitalopram Oxalate68%Trazodone Hcl32%Part D<11 patientsCholinesterase Inhibitor29.6%Donepezil Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:
- Clinical discovery and validation of delivery vectors to empower cures for CNS diseases
University of California, San Francisco
FY2026$2,656,684RM1NS143853 - Research Project II: AAV-CRISPR to Treat Amyotrophic Lateral Sclerosis
University of California Berkeley
FY2026$427,885U19NS132303
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Transplantation of Human IPSC-derived Microglia Ameliorates Neuropathology and Circuit Dysfunction in Progranulin-Deficient Mice
bioRxiv (Cold Spring Harbor Laboratory)
2026 - Arrayed dual-gRNA CRISPR screening platform for C9orf72 repeat expansion excision in patient iPSCs
Molecular Therapy Advances
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”